Trex Bio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.trex.bio
Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients
Phase 1
Not yet recruiting
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- TRex Bio, Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT06934252
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia